Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Comparison of Laboratory-Fabricated and 3D-Printed Rapid Maxillary Expansion Appliances

NCT07599202 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-08-07
Last updated
2026-09-04

Condition(s) studied

Maxillary Constriction

Investigational drug(s) / intervention(s)

Laboratory-fabricated rapid maxillary expansion appliance3D-printed rapid maxillary expansion appliance

Laboratory-fabricated rapid maxillary expansion appliance: A rapid maxillary expansion (RME) appliance fabricated on a dental cast obtained from conventional impressions. The expansion screw arms are adapted and soldered to orthodontic molar bands on the cast.

3D-printed rapid maxillary expansion appliance: A rapid maxillary expansion (RME) appliance fabricated using digital intraoral scan data. Dental models are generated from intraoral scans, and the appliance framework is manufactured as a single-piece structure using three-dimensional (3D) metal printing with sintered cobalt-chromium alloy.

Study summary

The goal of this clinical trial is to determine whether two types of rapid maxillary expansion (RME) appliances produce different outcomes in children. RME is a treatment utilized to expand a narrow upper jaw. This study will include children aged 8 to 10 years who need upper jaw expansion during the mixed dentition period (when they have both temporary and permanent teeth).

The main questions this study aims to answer are:

* Do 3D-printed expansion appliances produce different skeletal and dental changes compared to conventionally fabricated appliances?
* Do children feel more comfortable with one type of appliance?
* Is there a difference in pain levels or oral hygiene between the two groups?

Researchers aimed to compare a conventionally fabricated expansion appliance manufactured in a dental laboratory with a 3D-printed expansion appliance produced digitally to determine whether the method of production affects treatment outcomes and patient comfort.

Participants:

* Being treated with one of the two expansion appliances (assigned randomly)
* Follow a standard activation protocol at home with parental guidance
* Attend regular clinic visits during expansion and retention phases
* Have dental photographs, X-rays, and digital scans taken before and after treatment
* Complete an oral health-related quality of life questionnaire
* Rate their pain using a pain scale
* Have their oral hygiene measured

Eligibility

Sex
ALL
Min age
7 Years
Max age
11 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged between 7 and 11 years * In the mixed dentition period * Fully erupted permanent first molars * Presence of primary canines and primary second molars suitable for use as anchorage units for at least 6 months * Angle Class I or Class II molar relationship * Presence of posterior crossbite and/or moderate maxillary transverse deficiency or moderate crowding * Prepubertal growth stage corresponding to Cervical Vertebral Maturation Stage 1 (CVM1) or Stage 2 (CVM2) * Receiving orthodontic treatment at the Başkent University Department of Orthodontics * Parents or legal guardians willing to provide written informed consent Exclusion Criteria: * Previous orthodontic treatment * Periodontal disease * Enamel hypocalcification or significant calcium deficiency * Root resorption * Signs or symptoms of temporomandibular joint dysfunction * Angle Class III molar relationship * Craniofacial syndromes * Cleft lip and/or palate * Known allergy to acrylic materials or metal alloys * Inability to maintain adequate oral hygiene during treatment * Lack of cooperation during treatment * Repeated appliance breakage or dislodgement (three or more times)

Primary outcome measure(s)

  • Change in maxillary transverse skeletal width and intermolar width from T0 to T2 — -Preoperative (T0) -After appliance cementation (within 2 weeks) -1 week after the cementation -End of active expansion (approximately 6-8 weeks after cementation) (T1) -End of the 3 months retention period after T1, prior to appliance removal (T2)
    The primary outcome is the difference in transverse skeletal maxillary width and maxillary intermolar width between baseline (T0) and the end of the 3-month retention period (T2). Skeletal measurements will be obtained from standardized posteroanterior cephalometric radiographs, and dental measurements will be obtained from digital model analysis.

Trial sites (1)

FacilityCityRegionStatus
Baskent University Faculty of Dentistry, Department of Orthodontics Ankara Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07599202 on ClinicalTrials.gov ↗ ← All trials in Turkey